ACCORD HEALTHCARE, INC. recalls
6 notices naming ACCORD HEALTHCARE, INC. as the recalling firm, since December 11, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 11 more
Hazard (FDA): Subpotent Drug
FDAMedicines
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets
Hazard (FDA): Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.
FDAMedicines
ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets and 6 more
Hazard (FDA): Subpotent Drug: Assay below the approved specification
FDAMedicines